Biomedical and Metabolic Imaging Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, 10 Center Dr, Bldg 10, Room 3-5340, Bethesda, MD 20892, USA.
Radiology. 2012 Dec;265(3):715-23. doi: 10.1148/radiol.12120068. Epub 2012 Oct 9.
To develop a technique for time-resolved acquisition of phase-sensitive dual-inversion recovery (TRAPD) coronary vessel wall magnetic resonance (MR) images, to investigate the success rate in coronary wall imaging compared with that of single-frame imaging, and to assess vessel wall thickness in healthy subjects and subjects with risk factors for coronary artery disease (CAD).
Thirty-eight subjects (12 healthy subjects, 26 subjects with at least one CAD risk factor) provided informed consent for participation in this institutional review board-approved and HIPAA-compliant study. The TRAPD coronary vessel wall imaging sequence was developed and validated with a flow phantom. Time-resolved coronary artery wall images at three to five cine phases were obtained in all subjects. Qualitative and quantitative comparisons were made between TRAPD and conventional single-image wall measurements. Measurement reproducibility also was assessed. Statistical analysis was performed for all comparisons.
The TRAPD sequence successfully restored the negative polarity of lumen signal and enhanced lumen wall contrast on the cine images of the flow phantom and in all subjects. Use of three to five frames increased the success rate of acquiring at least one image of good to excellent quality from 76% in single-image acquisitions to 95% with the TRAPD sequence. The difference in vessel wall thickness between healthy subjects and subjects with CAD risk factors was significant (P < .05) with the TRAPD sequence (1.07 vs 1.46 mm, respectively; 36% increase) compared with single-frame dual inversion-recovery imaging (1.24 vs 1.55 mm, respectively; 25% increase). Intraobserver, interobserver, and interexamination agreement for wall thickness measurement were 0.98, 0.97, and 0.92, respectively.
TRAPD imaging of coronary arteries improved arterial wall visualization and quantitative assessment by increasing the success rate of obtaining good- to excellent-quality images and sections orthogonal to the longitudinal axis of the vessel. This also resulted in vessel wall thickness measurements that show a more distinct difference between healthy subjects and those with CAD risk factors.
http://radiology.rsna.org/lookup/suppl/doi:10.1148/radiol.12120068/-/DC1.
开发一种时间分辨采集相位敏感双反转恢复(TRAPD)冠状动脉血管壁磁共振(MR)图像的技术,比较冠状动脉壁成像的成功率与单帧成像,评估健康受试者和冠心病(CAD)危险因素患者的血管壁厚度。
38 名受试者(12 名健康受试者,26 名至少有 1 个 CAD 危险因素)自愿参加本项经机构审查委员会批准和 HIPAA 合规的研究,并提供知情同意书。开发并验证了 TRAPD 冠状动脉血管壁成像序列,采用血流体模。对所有受试者进行 3 到 5 个电影相位的时间分辨冠状动脉壁图像采集。对 TRAPD 和常规单帧壁测量进行定性和定量比较。还评估了测量可重复性。对所有比较进行统计学分析。
TRAPD 序列成功恢复了流变体模和所有受试者的电影图像中管腔信号的负极性并增强了管腔壁对比度。与单帧采集相比,使用 3 到 5 个帧可将至少获得 1 个质量良好至优秀图像的成功率从 76%提高到 95%,采用 TRAPD 序列。与单帧双反转恢复成像(分别为 1.24 和 1.55 mm,分别增加 25%)相比,TRAPD 序列(分别为 1.07 和 1.46 mm,分别增加 36%)可显著测量出健康受试者和 CAD 危险因素患者之间的血管壁厚度差异(P <.05)。壁厚度测量的观察者内、观察者间和检查间一致性分别为 0.98、0.97 和 0.92。
通过增加获得质量良好至优秀图像和与血管长轴正交节段的成功率,TRAPD 冠状动脉成像改善了动脉壁可视化和定量评估。这也导致健康受试者和 CAD 危险因素患者之间的血管壁厚度测量差异更加明显。
http://radiology.rsna.org/lookup/suppl/doi:10.1148/radiol.12120068/-/DC1.